{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:21Z","timestamp":1753890681941,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2021.772876","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T06:41:59Z","timestamp":1633416119000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Fahimeh","family":"Varzideh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urna","family":"Kansakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislovas S.","family":"Jankauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Santulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(01)00443-X","article-title":"Cardiovascular Endocrinology: Into the New Millennium","volume":"12","author":"Funder","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrendo.2017.155","article-title":"Cardiovascular Endocrinology: Long-Term Safety of Growth Hormone","volume":"14","author":"Bradley","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-2061","article-title":"Classics in Cardiovascular Endocrinology: Aldosterone Action Beyond Electrolytes","volume":"157","author":"Auchus","year":"2016","journal-title":"Endocrinology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2014.04.002","article-title":"Adropin: A New Regulatory Peptide in Cardiovascular Endocrinology","author":"Goetze","year":"2014","journal-title":"Regul Pept"},{"key":"B5","article-title":"Heart Failure and Cardiovascular Endocrinology: Heart and Hormones","volume":"12","author":"Twickler","year":"2004","journal-title":"Neth Heart J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.88","article-title":"Cardiovascular Endocrinology: Is ANGPTL3 the Next PCSK9","volume":"13","author":"Musunuru","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13078","article-title":"Diagnosing Endocrine Hypertension: A Practical Approach","volume":"22","author":"Yang","year":"2017","journal-title":"Nephrol (Carlton)"},{"key":"B8","article-title":"Overview of Endocrine Hypertension","volume-title":"Endotext","author":"Koch","year":"2000"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-Sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, Diagnosis, Management and Future Directions of Research of Phaeochromocytoma and Paraganglioma: A Position Statement and Consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02783-1","article-title":"Extending the Endocrine Hypertension Spectrum: Novel Nonclassic Apparent Mineralocorticoid Excess","author":"Carvajal","year":"2021","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.15566","article-title":"Heart Failure With Preserved Ejection Fraction: Time for a Reset","volume":"324","author":"Clark","year":"2020","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.695952","article-title":"Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-Resolving Inflammation in Obesity","volume":"8","author":"Tourki","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-020-0798-y","article-title":"Microvascular and Lymphatic Dysfunction in HFpEF and Its Associated Comorbidities","volume":"115","author":"Cuijpers","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00110","article-title":"Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales","volume":"6","author":"Oh","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-Directional Analysis Between Fatty Liver and Cardiovascular Disease Risk Factors","volume":"66","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and Cardiovascular Diseases: A Clinical Review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0101-8","article-title":"Evolving Concepts in the Pathogenesis of Uraemic Cardiomyopathy","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Nephrol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.772876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T06:42:01Z","timestamp":1633416121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.772876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":20,"alternative-id":["10.3389\/fendo.2021.772876"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.772876","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"article-number":"772876"}}